Nazgul Sakenova
@nazgulsakenova.bsky.social
PostDoc in Bernhardt lab at Harvard | bacterial cell biology
PhD @typaslab.bsky.social at EMBL | systems microbiology
PhD @typaslab.bsky.social at EMBL | systems microbiology
Antibiotic (abx) resistance is outpacing new abx discovery. This is worsened by cross-resistance (XR) between abx. However, resistance can also lead to collateral sensitivity (CS) to other abx, providing new treatment opportunities. In our new preprint www.biorxiv.org/content/10.1...
January 29, 2024 at 10:09 PM
Antibiotic (abx) resistance is outpacing new abx discovery. This is worsened by cross-resistance (XR) between abx. However, resistance can also lead to collateral sensitivity (CS) to other abx, providing new treatment opportunities. In our new preprint www.biorxiv.org/content/10.1...